2025-07-31 - Analysis Report
Okay, here's the analysis of Colgate-Palmolive (CL) based on the provided data, formatted as requested:

## Colgate-Palmolive (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co. is a global consumer products company focusing on oral care, personal care, home care, and pet nutrition.

### 1.  Performance vs. S&P 500 (VOO)

*   **CL Cumulative Return:** 13.63%
*   **VOO Cumulative Return:** 98.84%
*   **Absolute Divergence (CL - VOO):** -85.1%
*   **Divergence Range:** Max: 7.9, Min: -85.7
*   **Relative Divergence:** 0.6  (Indicates CL's divergence is near its historical low relative to VOO).

**Analysis:**  Colgate-Palmolive has significantly underperformed the S&P 500 over the period.  The relative divergence suggests this underperformance is near its historical worst.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.5% | -16.0% | 0.0 | 61.1 |
| 2016-2018  | -11.0% | 65.2% | -29.0% | 0.1 | 48.2 |
| 2017-2019  | 7.0% | 65.2% | -22.0% | 0.1 | 55.8 |
| 2018-2020  | 18.0% | 65.2% | -2.0% | 0.6 | 69.3 |
| 2019-2021  | 30.0% | 58.6% | -19.0% | 0.7 | 69.2 |
| 2020-2022  | 7.0% | 69.0% | 5.0% | 0.7 | 63.9 |
| 2021-2023  | 6.0% | 69.0% | -12.0% | 0.8 | 64.6 |
| 2022-2024  | 13.0% | 69.0% | -12.0% | 0.8 | 73.7 |
| 2023-2025  | 0.0% | 70.6% | -50.0% | 0.3 | 69.5 |

**Analysis of Table:**

*   **Alpha:** The alpha values are predominantly negative, indicating underperformance relative to the benchmark across most periods.  The negative alpha in the most recent period (2023-2025) is particularly significant.
*   **Beta:** Beta values are generally low (close to 0 or below 1), suggesting CL's price is less sensitive to market movements compared to the S&P 500.
*   **CAGR (Compound Annual Growth Rate):**  CAGR varies significantly across different periods, with some years showing positive growth and others negative. Recent years show a deceleration of growth.
*   **MDD (Maximum Drawdown):** MDD values are high, particularly in the later periods, showing very high volatility
*   **Cap(B) (Capitalization in Billions):** The market capitalization of the company has fluctuated over the years.

### 2. Recent Stock Price Movement

*   **Current Price:** \$85.78
*   **Previous Close:** \$86.86
*   **Change:** -\$1.24 (approximately -1.43% decrease)
*   **5-day Moving Average:** \$87.10
*   **20-day Moving Average:** \$89.01
*   **60-day Moving Average:** \$89.96

**Analysis:** The stock price is currently below its 5, 20, and 60-day moving averages, indicating a short-term downward trend. The recent price decrease (change of -\$1.24) suggests further recent negative momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3349 (Low Risk)
*   **RSI (Relative Strength Index):** 25.60 (Oversold)
*   **PPO (Percentage Price Oscillator):** -0.2633
*   **Hybrid Signal:** cash_70%_Sell 69.9% of holdings (1169 shares - Caution - MRI:0.34) (Cash Ratio: 70% on 2025-07-16)
*   **20-day Relative Divergence Change:** -0.3 (Short-term decrease)
*   **Expected Return:** -3586% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:**  A low MRI suggests relatively low market risk overall.
*   **RSI:** The RSI indicates the stock is currently oversold, which could suggest a potential for a price rebound, although oversold conditions can persist.
*   **PPO:** The negative PPO value indicates a bearish trend.
*   **Hybrid Signal:** Hybrid Signal strongly recommends reducing holdings and increasing cash position to 70%.
*   **Relative Divergence Change:** The decrease in relative divergence over the past 20 days confirms the recent underperformance.
*   **Expected Return:** The extremely negative expected return is a significant red flag, implying a very pessimistic outlook for CL relative to the S&P 500 over the long term.
*   **Significant Price Change:** The price decreased by $1.24 (approximately -1.43%), indicating a notable downward movement that might warrant further investigation into potential influencing factors.

### 4. Recent News & Significant Events

*   **2025-07-31:** Business developments, regulatory changes, or market events are impacting CL.
*   **2025-07-29:** Analysts are discussing CL's performance in the context of industry and economic trends.
*   **2025-07-28:**  CL's stock is exhibiting notable volatility, influenced by news, earnings, or executive actions.
*   **2025-07-30:** Market experts highlight both risks and opportunities and advise monitoring news.

**Analysis:** Recent news suggests a dynamic environment for Colgate-Palmolive, with analysts actively discussing performance, potential volatility, and emerging risks and opportunities. These news items should be investigated to understand the specific drivers behind the stock's movements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-04-25 | 0.85 | 4.91 B\$  |
| 2024-10-25 | 0.9  | 5.03 B\$  |
| 2024-07-26 | 0.89 | 5.06 B\$  |
| 2024-04-26 | 0.83 | 5.07 B\$  |
| 2025-04-25 | 0.83 | 5.07 B\$  |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has shown some fluctuation over the past few quarters, however, 2025-04-25's EPS is showing as a duplicate value.
*   **Revenue:** Revenue has been relatively stable, with slight decreases in the most recent quarter (compared to the previous year). It shows a recent downward trend.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | \$4.91B  | 60.82%         |
| 2024-12-31   | \$4.95B  | 60.30%         |
| 2024-09-30   | \$5.03B  | 61.08%         |
| 2024-06-30   | \$5.06B  | 60.62%         |
| 2024-03-31   | \$5.07B  | 60.00%         |

**Capital and Profitability:**

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-03-31   | \$0.36B  | 190.08%    |
| 2024-12-31   | \$0.21B  | 348.58%    |
| 2024-09-30   | \$0.43B  | 169.43%    |
| 2024-06-30   | \$0.12B  | 594.31%    |
| 2024-03-31   | \$0.23B  | 296.96%    |

**Analysis:**

*   **Revenue:**  Revenue shows a slight downward trend in recent quarters.
*   **Profit Margin:**  Profit margins have remained relatively stable and high, indicating strong operational efficiency.
*   **Equity:** Equity has fluctuated significantly.
*   **ROE (Return on Equity):** ROE is very high in all periods, but varies significantly, implying significant earnings in comparison to equity values. The wide fluctuations indicate volatility in profitability relative to equity.  The low equity values likely contribute to the very high ROE.

### 7. 종합 결론 (Overall Conclusion)

Colgate-Palmolive (CL) is currently exhibiting several concerning indicators:

*   **Significant Underperformance:**  It has substantially underperformed the S&P 500, and this divergence is near its historical worst.
*   **Negative Momentum:** The stock price is below its moving averages and has recently declined.
*   **Oversold Condition:** While oversold, this doesn't guarantee a rebound, especially with other negative signals.
*   **Pessimistic Outlook:** The extremely negative expected return suggests a lack of confidence in CL's ability to outperform the market in the long term.
*   **Recent News & Volatility:** Recent news highlights ongoing developments and volatility, requiring further investigation.
*   **Revenue Decline:** Slight decrease in recent revenue.
*   **High ROE with Fluctuations:** very high ROE numbers are likely due to low equity, and the numbers fluctuate significantly.

**Recommendation:** Based on this analysis, a *cautious* approach to Colgate-Palmolive is warranted. The Hybrid Signal's recommendation to significantly reduce holdings should be seriously considered. Before making any investment decisions, investors should conduct further due diligence, investigate the specific news events, and carefully consider their risk tolerance and investment objectives.

